4,4,5,5-tetramethyl-2-(4-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane

We are 4,4,5,5-tetramethyl-2-(4-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane CAS:1158227-59-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4,4,5,5-tetramethyl-2-(4-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane
CAS.NO:1158227-59-8
Synonyms:/
Molecular Formula:C30H27BO2
Molecular Weight:430.34500
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

4,4,5,5-tetramethyl-2-(4-(triphenylen-2-yl)phenyl)-1,3,2-dioxaborolane


Related News: The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.1-Methylazepan-4-one Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.Ácido 4-propan-2-il-1,3-tiazol-2-carboxílico CAS:300831-06-5 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.90555-65-0 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
2-Chloro-4-bromo-5-fluorobenzaldehyde View Details
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene View Details
5-Bromo-2-chloroisonicotinic acid View Details
Sodium hyaluronate manufacturer 2-((4-Methyl-2-nitrophenyl)amino)ethanol manufacturer Perfluoroalkylethanol Cas:68391-08-2 manufacturer Sodium L-Ascorbyl-2-Phosphate manufacturer 1-Bromo-3-phenylpropane Cas:637-59-2 manufacturer